Soleno Therapeutics Inc (SLNO)
EBITDA Growth
187.62%
Quarterly · Period ending:
SLNO EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported187.62%period ending
Latest reported187.62%period ending
SLNO Quarterly EBITDA YoY % (-134.37% → 187.62%)
Year-over-year change
High-resolution chart · PNG
SLNO ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 187.6181% | |
| 191.3898% | |
| 135.3967% | |
| 86.7509% | |
| -100.44% | |
| -300.94% | |
| -788.6822% | |
| -173.1109% | |
| -172.2396% | |
| -115.5835% | |
| -58.1002% | |
| -37.9122% | |
| -25.1018% | |
| 1.9527% | |
| 22.5321% | |
| 24.9967% | |
| 36.4098% | |
| 20.3438% | |
| -9.8423% | |
| 3.8408% | |
| -17.6026% | |
| -14.6948% | |
| -17.4354% | |
| -58.8164% | |
| -91.6647% | |
| -823.6693% | |
| -77.6899% | |
| -65.6407% | |
| -67.6321% | |
| 141.5529% | |
| -45.488% | |
| -18.7525% | |
| -103.748% | |
| 16.8089% | |
| -12.5972% | |
| -10.8811% | |
| 70.4454% | |
| 26.1216% | |
| 40.2416% | |
| 25.033% | |
| -75.9851% | |
| -88.1936% | |
| -145.1025% | |
| -132.9231% | |
| -256.13% | |
| -180.9787% | |
| -30.7492% | |
| -9.0243% | |
| -134.3738% |